New cancer vaccine that trains body's immune system to destroy cancer cells shows promising results

Cancer Vaccine: A new mRNA cancer vaccine developed by Moderna has shown promising early results in clinical trials. The vaccine, mRNA-4359, aims to activate the immune system to target and destroy cancer cells. In a phase-one trial with 19 patients, eight showed no tumour growth. The study is ongoing with melanoma and lung cancer patients.